CHRISTIANSON MARK (Business Development Director) sold 3.7% of their position (10K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $5.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2025ACC: 0001709738-25-000007
Officer· Business Development Director
Since Feb 2026
-10K
Net shares
Net seller
$5.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$0.58
Trade value
$5.80K
% of position
3.7%
6/4/2025
271.49K→261.49K
Total
Net shares
−10K
Net value
-$5.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2025 | S · Sale | −10K | $0.58 | $5.80K | 3.7% | 271.49K | 261.49K |
| Total | −10K | -$5.80K | ||||||
Derivative Transactions0
No derivative transactions reported